1. Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219. (July 2019) Authors: Melosky, Barbara; Bradbury, Penelope; Tu, Dongsheng; Florescu, Marie; Reiman, Anthony; Nicholas, Garth; Basappa, Naveen; Rothenstein, Jeffrey; Goffin, John R.; Laurie, Scott A.; Wheatley-Price, Paul; Leighl, Natasha; Goss, Glenwood; Reaume, M. Neil; Butts, Charles; Murray, Nevin; Card, Cynthia; K... Journal: Lung cancer Issue: Volume 133(2019) Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗